ProAssurance Co. (NYSE:PRA) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP lowered its holdings in ProAssurance Co. (NYSE:PRA) by 5.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,987,196 shares of the insurance provider’s stock after selling 176,889 shares during the period. Wellington Management Group LLP owned about 5.84% of ProAssurance worth $47,526,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in PRA. State Street Corp grew its position in ProAssurance by 1.8% in the third quarter. State Street Corp now owns 1,968,754 shares of the insurance provider’s stock worth $29,610,000 after buying an additional 34,247 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of ProAssurance by 0.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,316,249 shares of the insurance provider’s stock worth $20,678,000 after purchasing an additional 4,814 shares during the period. Arrowstreet Capital Limited Partnership raised its position in shares of ProAssurance by 92.1% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 690,871 shares of the insurance provider’s stock worth $10,992,000 after purchasing an additional 331,224 shares during the period. American Century Companies Inc. lifted its holdings in shares of ProAssurance by 17.2% during the fourth quarter. American Century Companies Inc. now owns 391,609 shares of the insurance provider’s stock valued at $6,230,000 after purchasing an additional 57,556 shares during the last quarter. Finally, Zacks Investment Management acquired a new position in shares of ProAssurance in the 3rd quarter valued at $5,140,000. 85.58% of the stock is currently owned by institutional investors.

ProAssurance Trading Down 0.4 %

Shares of NYSE PRA opened at $23.26 on Friday. The firm has a market capitalization of $1.19 billion, a PE ratio of 28.02 and a beta of -0.09. ProAssurance Co. has a one year low of $10.76 and a one year high of $23.43. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The business has a 50-day moving average price of $17.07 and a two-hundred day moving average price of $16.12.

ProAssurance (NYSE:PRA) last announced its quarterly earnings data on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.19. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The firm had revenue of $287.52 million for the quarter, compared to the consensus estimate of $274.56 million. As a group, analysts predict that ProAssurance Co. will post 0.8 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Citizens Jmp downgraded ProAssurance from an “outperform” rating to a “market perform” rating in a report on Thursday. StockNews.com initiated coverage on shares of ProAssurance in a report on Tuesday, April 1st. They set a “hold” rating on the stock. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, ProAssurance currently has an average rating of “Hold” and a consensus price target of $18.67.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.